Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.3, with the notable removal of FDA Safety Alerts and Recalls from the previous version 2.10.2.
    Difference
    0.2%
    Check dated 2024-09-04T06:35:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T01:08:08.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    47 days ago
    Change Detected
    Summary
    The study has expanded to include 136 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T15:29:38.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:33:01.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The change in the web page value represents the addition of a DOI (Digital Object Identifier) for the erratum related to the publication in Lancet Oncol. 2021 Oct;22(10):e428.
    Difference
    0.1%
    Check dated 2024-07-03T15:38:43.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T15:23:00.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.